Early-Phase Partial Mayo Score following Golimumab Treatment Is Associated with Endoscopic Improvement at 1 Year in Ulcerative Colitis: A post hoc Analysis of PURSUIT-J Randomized...

por Nagano, Katsumasa, Imai, Yuya, Ukyo, Yoshifumi, Kobayashi, Taku, Yokoyama, Seiji
Publicado 2022

Apelin elevates blood pressure in ICR mice with L-NAME-induced endothelial dysfunction

por NAGANO, KATSUMASA, ISHIDA, JUNJI, UNNO, MADOKA, MATSUKURA, TANOMU, FUKAMIZU, AKIYOSHI
Publicado 2013

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective obs...

por Matsuoka, Katsuyoshi, Nagano, Katsumasa, Nagasaki, Shinya, Murata, Yoko, Hisamatsu, Tadakazu
Publicado 2022

Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post‐marketing surveillance in Japan

por Yokoyama, Seiji, Asano, Teita, Nagano, Katsumasa, Tsuchiya, Hiroaki, Takagishi, Masayuki, Tsujioka, Shigeharu, Miura, Naomi, Matsumoto, Takayuki
Publicado 2021

Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed

por Nagano, Katsumasa, Hata, Erina, Asano, Teita, Tsuchiya, Hiroaki, Takagishi, Masayuki, Yamazaki, Hiroshi, Tominaga, Sonoko, Matsumoto, Takayuki
Publicado 2023